Beijing Prohibits Drug Price Mark-up Beyond 15 Percent
This article was originally published in PharmAsia News
Executive Summary
Beijing's Development and Reform Commission recently announced that all municipal county-level and higher medical institutions will be strictly prohibited from increasing drug prices beyond 15 percent of actual procurement prices
Beijing's Development and Reform Commission recently announced that all municipal county-level and higher medical institutions will be strictly prohibited from increasing drug prices beyond 15 percent of actual procurement prices. It is also reported that Beijing has plans to review and re-set actual drug trade prices that differ greatly from government-led prices. Due to myriad reports of exorbitant drug prices, market-guided pricing will give way to government-set pricing, including drug cost assessments. Meanwhile, the drug price certification department will cease certification of market-adjusted drug prices while also cleaning up and removing drugs of uncertified price. (Click Here For More - Chinese Language) "Drug Price Increase Rate Cannot Exceed 15%"- finance.sina.com.cn (6.03.10) |